Suppr超能文献

急性缺血性卒中介入治疗中的经桡动脉入路

Transradial access in acute ischemic stroke intervention.

作者信息

Haussen Diogo C, Nogueira Raul G, DeSousa Keith G, Pafford Ryan N, Janjua Nazli, Ramdas Kevin N, Peterson Eric C, Elhammady Mohamed Samy, Yavagal Dileep R

机构信息

Departments of Neurology, Neurosurgery and Radiology, Emory University School of Medicine/Grady Memorial Hospital Marcus Stroke and Neuroscience Center, Atlanta, Georgia.

University of Miami Leonard M. Miller School of Medicine/Jackson Memorial Hospital, Miami, Florida.

出版信息

J Neurointerv Surg. 2016 Mar;8(3):247-50. doi: 10.1136/neurintsurg-2014-011519. Epub 2015 Jan 5.

Abstract

OBJECTIVE

To describe the feasibility and safety of transradial access (TRA) in the interventional management of acute ischemic stroke (AIS).

METHODS

A retrospective review of the local institutional AIS interventional databases of three tertiary academic centers was performed and the use of TRA identified.

RESULTS

TRA was attempted in 15 (1.5%) of 1001 patients; it was used in 12 cases due to transfemoral access (TFA) failure and in 3 as the primary strategy. The mean age was 72.3±8.6 and 46% were male. Baseline National Institutes of Health Stroke Scale score was 19.5±8.7, two patients (14%) received intravenous tissue plasminogen activator, and mean time from last known normal to intra-arterial therapy was 17.0±20.1 h. Five patients had anterior circulation occlusive disease and 10 had vertebrobasilar occlusions. TRA was effective in allowing clot engagement in 13 of 15 cases: one patient had a hypoplastic radial artery that precluded sheath advancement and one had chronic innominate artery occlusion that could not be crossed. Mean time to switch from TFA to TRA was 1.9±1.3 h and the mean time from radial puncture to reperfusion was 2.2±1.0 h. Modified Thrombolysis In Cerebral Infarction 2b-3 reperfusion via TRA was achieved in 9 of 15 patients (60%). No radial puncture site complications were noted. At 90 days, two patients (13%) had a good clinical outcome and seven (50%) had died.

CONCLUSIONS

Failure of TFA in the endovascular treatment of AIS is uncommon but leads to unacceptable delays in reperfusion and poor outcomes. Standardization of benchmarks for access switch could serve as a guide for neurointerventionalists. TRA is a valid approach for the endovascular treatment of AIS.

摘要

目的

描述经桡动脉入路(TRA)在急性缺血性卒中(AIS)介入治疗中的可行性和安全性。

方法

对三个三级学术中心的本地机构AIS介入数据库进行回顾性分析,并确定TRA的使用情况。

结果

1001例患者中有15例(1.5%)尝试TRA;12例因经股动脉入路(TFA)失败而使用TRA,3例作为主要策略使用TRA。平均年龄为72.3±8.6岁,46%为男性。基线美国国立卫生研究院卒中量表评分为19.5±8.7,2例患者(14%)接受静脉注射组织纤溶酶原激活剂,从最后一次已知正常到动脉内治疗的平均时间为17.0±20.1小时。5例患者有前循环闭塞性疾病,10例有椎基底动脉闭塞。TRA在15例中的13例有效地实现了血栓介入:1例患者桡动脉发育不全,无法推进鞘管,1例有慢性无名动脉闭塞,无法通过。从TFA转换为TRA的平均时间为1.9±1.3小时,从桡动脉穿刺到再灌注的平均时间为2.2±1.0小时。15例患者中有9例(60%)通过TRA实现了改良脑梗死溶栓2b-3级再灌注。未发现桡动脉穿刺部位并发症。在90天时,2例患者(13%)临床结局良好,7例(50%)死亡。

结论

TFA在AIS血管内治疗中失败并不常见,但会导致再灌注延迟且结局不佳。接入转换基准的标准化可为神经介入医生提供指导。TRA是AIS血管内治疗的一种有效方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验